Unique Case of a Large Indolent Medullary Thyroid Carcinoma: Time to Reconsider the Medullary Thyroid Adenoma Entity?

Journal: European thyroid journal
Published Date: Dec 6, 2018

Abstract

BACKGROUND: Medullary thyroid carcinoma (MTC) is a rare neuroendocrine cancer originating from parafollicular, calcitonin (Ctn)-producing C-cells. Prognosis correlates with primary tumor stage and Ctn levels.

Authors

  • Simona Censi
    Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.
  • Elisabetta Cavedon
    Familial Tumor Unit, Veneto Institute of Oncology, (IOV)-IRCCS, Padua, Italy.
  • Sara Watutantrige-Fernando
    Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.
  • Susi Barollo
    Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.
  • Loris Bertazza
    Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.
  • Jacopo Manso
    Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.
  • Maurizio Iacobone
    Surgery Unit, Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University of Padua, Padua, Italy.
  • Davide Nacamulli
    Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.
  • Francesca Galuppini
    Surgical Pathology & Cytopathology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.
  • Gianmaria Pennelli
    Surgical Pathology & Cytopathology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.
  • Caterina Mian
    Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals